Related references
Note: Only part of the references are listed.RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells
Paul R. Reynolds et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Advanced glycation end product homeostasis - Exogenous oxidants and innate defenses
Helen Vlassara et al.
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES (2008)
The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease
Mariella Catalano et al.
CLINICAL BIOCHEMISTRY (2008)
Identification, classification, and expression of RAGE gene splice variants
Barry I. Hudson et al.
FASEB JOURNAL (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts
H. L. Nienhuis et al.
RHEUMATOLOGY (2008)
Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjogren's syndrome
Carol Stewart et al.
RHEUMATOLOGY INTERNATIONAL (2008)
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers
Joan Montaner et al.
STROKE (2008)
Acute Kawasaki disease is associated with reverse regulation of with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12
Helmut Wittkowski et al.
ARTHRITIS AND RHEUMATISM (2007)
Decreased plasma soluble RAGE in patients with hypercholesterolemia:: Effects of statins
Francesca Santilli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes
Tetsuya Sugiyama et al.
EXPERIMENTAL EYE RESEARCH (2007)
Soluble RAGE in type 2 diabetes: Association with oxidative stress
Eleonora Devangelio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via ß2 integrin Mac-1
Rille Pullerits et al.
ARTHRITIS AND RHEUMATISM (2006)
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein
Giuseppina Basta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects
Sho-ichi Yamagishi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans
Diego Geroldi et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis
H Koyama et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia
E Emanuele et al.
ARCHIVES OF NEUROLOGY (2005)
Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis
S Drinda et al.
RHEUMATOLOGY INTERNATIONAL (2005)
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy
JM Forbes et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
C Falcone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Accelerated atherosclerosis in patients with Wegener's granulomatosis
K de Leeuw et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
R Pullerits et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Receptor of advanced glycation end product (RAGE) expression in the minor salivary glands of patients with Sjogren's syndrome: a preliminary study
J Katz et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)
The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products
E Boulanger et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor
C Iacobini et al.
FASEB JOURNAL (2004)
Protein glycation - A firm link to endothelial cell dysfunction
JL Wautier et al.
CIRCULATION RESEARCH (2004)
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
T Chavakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis
R Pullerits et al.
ARTHRITIS AND RHEUMATISM (2003)
S100A12 (EN-RAGE) in monitoring Kawasaki disease
D Foell et al.
LANCET (2003)
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
H Yonekura et al.
BIOCHEMICAL JOURNAL (2003)
Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system
SS Yan et al.
NATURE MEDICINE (2003)
Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry
PJ Thornalley et al.
BIOCHEMICAL JOURNAL (2003)
Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings
D Stern et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice
LG Bucciarelli et al.
CIRCULATION (2002)
High mobility group box chromosomal protein 1 - A novel proinflammatory mediator in synovitis
R Kokkola et al.
ARTHRITIS AND RHEUMATISM (2002)
RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease
LG Bucciarelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response
MA Hofmann et al.
GENES AND IMMUNITY (2002)
AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression
E Boulanger et al.
KIDNEY INTERNATIONAL (2002)
Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice
G Pugliese et al.
FASEB JOURNAL (2001)
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice
MT Goova et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
